| Old Articles: <Older 17341-17350 Newer> |
 |
The Motley Fool October 12, 2006 Chuck Saletta |
Dueling Fools: Select Comfort Bear Rebuttal Investors, the company's growth will eventually be caught napping.  |
The Motley Fool October 12, 2006 Rick Aristotle Munarriz |
Dueling Fools: Select Comfort Bull Rebuttal Investors, Select Comfort is not just a lucky player in a cyclical big-ticket sector. These aren't cars, boats or homes here.  |
The Motley Fool October 12, 2006 Chuck Saletta |
Dueling Fools: Select Comfort Bear With Select Comfort's stock now trading in line with the largest public firm in the industry, future share price growth depends on operational growth that may not materialize. New shareholders simply cannot count on the success of the past to propel their holding forward in the future.  |
The Motley Fool October 12, 2006 Rick Aristotle Munarriz |
Dueling Fools: Select Comfort Bull Investors, sleep better at night with this company.  |
The Motley Fool October 12, 2006 David Meier |
Bed Bath & Beyond Comprehension The company tries to absolve itself in the stock options controversy, but doesn't. Investors, corporate America is just greedy, and this whole backdating issue exposes another layer of that problem.  |
The Motley Fool October 12, 2006 Rich Smith |
General Dynamics Outflanked? Investors, beware of the horn tooters when it comes to who's competing for an armored-vehicle contract.  |
The Motley Fool October 12, 2006 Rich Smith |
Noble Investing Lessons What manufactured-home builder Nobility Homes teaches investors about small companies and smaller time frames.  |
The Motley Fool October 12, 2006 Rick Aristotle Munarriz |
Disney's New Stores Disney's going in a new direction in retailing. Investors, take note.  |
The Motley Fool October 12, 2006 Ryan Fuhrmann |
Super Quarter at SUPERVALU Will SUPERVALU's giant acquisition of Albertsons jump-start top-line growth for the grocery store chain? Investors, take note.  |
The Motley Fool October 12, 2006 Brian Lawler |
Genzyme Runs a Tight Ship Revenues are up at the biopharmaceutical company, but shares dropped in morning trading.  |
| <Older 17341-17350 Newer> Return to current articles. |